NIH-funded research R01 grant

Web-based pain coping skills training to help breast cancer survivors on aromatase inhibitors feel better and stay adherent

Official title: Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial

Funded at Northwestern University · NIH-11389373 · Data updated 2026-11-12

A patient-friendly, online program uses coping skills to relieve AI-related joint pain and improve taking AI medication.

More Breast Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNorthwestern University
NIH-funded
Lab location1 site (Chicago, United States)
Project startJune 1, 2022
Project endMay 31, 2027
Funding year2026
Award (this year)$638,144
NIH project number5R01CA271220-05
Project IDNIH-11389373 on NIH RePORTER

Who could benefit from this research

Could help

Postmenopausal breast cancer survivors with HR+ tumors who are using aromatase inhibitors and experiencing arthralgia.

Less likely to help

Patients without AI-related joint pain or those unable to use or access online interventions may see less direct benefit.

What this research studies

This project offers a web-based cognitive-behavioral therapy–informed program to help postmenopausal breast cancer survivors manage AI-associated joint pain. It will be delivered online to fit into patients’ lives and aims to reduce pain and improve consistency in taking aromatase inhibitors. The approach builds practical skills for coping with discomfort and sticking with treatment, with support from trained therapists when needed. If successful, it could lead to better quality of life and fewer AI-related adherence problems for many survivors.

Why it matters

Potential benefit: If successful, patients may experience less pain and better ability to stay on AI therapy, potentially improving long-term cancer outcomes.

How similar studies have gone: Past trials show PCST can reduce pain and disability in cancer and other conditions, but this exact AI-related arthralgia application is novel.

Where this research is happening

  • Northwestern University
    Chicago, United States
    Active

Researchers

  • Principal investigator: Rini, Christine — Northwestern University
  • Study coordinator: Rini, Christine

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.